ProfileOfResearchers

NO MEU:

TÃTULO: Supplementary Table S2 from Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller ; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025

INDEXADO EM:

NO MEU:

TÃTULO: Supplementary Table S3 from Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller ; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025

INDEXADO EM:

NO MEU:

TÃTULO: Surgical Staging Identifies Occult Metastases in Over 50% of Uterine-Confined Carcinosarcoma
AUTORES: William Vintzileos; Hannah Beer; David Scott Miller ; Jayanthi Lea;
PUBLICAÇÃO: 2025

INDEXADO EM:

NO MEU:

TÃTULO: Surgical staging identifies occult metastases in over 50% of uterine-confined carcinosarcoma
AUTORES: William Vintzileos; Hannah Beer; David Scott Miller ; Jayanthi Lea;
PUBLICAÇÃO: 2025, FONTE: Gynecologic Oncology Reports, VOLUME: 58

INDEXADO EM:

Scopus

Unpaywall

NO MEU:

TÃTULO: 187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
AUTORES: Jalid Sehouli; Ignace Vergote; Erika Hamilton; Alejandro Pérez Fidalgo; Toon Van Gorp; Giovanni Scambia; Jaroslav Klat; Tally Levy; Stephen Welch; Debra L Richardson; Eva Maria Guerra Alía; Stéphanie Henry; Pauline Wimberger; David Scott Miller ; Jerónimo Martínez; Bradley J Monk; Pratheek Kalyanapu; Monsoor Raza Mirza; Vicky Makker;
PUBLICAÇÃO: 2024, FONTE: Oral Sessions

INDEXADO EM:

CrossRef: 2

NO MEU:

ORCID |

TÃTULO: Dose-expansion part of a phase 1b global study of E7386 in combination with lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC) and other solid tumors including endometrial cancer (EC).
AUTORES: Jung-Yun Lee; Baek-Yeol Ryoo; Jin Won Kim; Ann-Lii Cheng; Richard S Finn; Kosei Hasegawa; Vicky Makker; Masatoshi Kudo; David Scott Miller ; Philippe Merle; Susanna Varkey Ulahannan; Tetsuya Hosaka; Takatoshi Sahara; Cixin S He; Karen O'Hara; Lea Dutta; Toshiyuki Tamai; Masafumi Ikeda;
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology, VOLUME: 42, NÚMERO: 16_suppl

INDEXADO EM:

NO MEU:

ORCID |

TÃTULO: Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study Full Text
AUTORES: Vicky Makker; Jose Alejandro Perez Fidalgo; Giorgio Valabrega; Erika Hamilton; Toon Van Gorp; Jalid Sehouli; Klaudia Regináčová; Debra L Richardson; Tamar Perri; Amit M Oza; David Scott Miller ; Eva Maria Guerra Alía; Ugo De Giorgi; Stephanie Henry; Daniel L Spitz; Pauline Wimberger; Markéta Bednaříková; Hye Sook Chon; Jerónimo Martínez Garcia; Carmela Pisano; Jonathan S Berek; Ignacio Romero; Giovanni Scambia; Lorena Fariñas Madrid; Joseph Buscema; Fabienne Schochter; Kai Li; Pratheek Kalyanapu; Christopher J Walker; Ignace Vergote; ...Mais
PUBLICAÇÃO: 2024, FONTE: Gynecologic Oncology, VOLUME: 185

INDEXADO EM:

Scopus

CrossRef: 3

NO MEU:

ORCID |

TÃTULO: NCCN GUIDELINES® INSIGHTS CE Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Featured Updates to the NCCN Guidelines
AUTORES: Joyce Liu; Andrew Berchuck; Floor J Backes; Joshua Cohen; Rachel Grisham; Charles A Leath; Lainie Martin; Daniela Matei; David Scott Miller ; Sharon Robertson; Lisa Barroilhet; Shitanshu Uppal; Andrea Wahner Hendrickson; David M Gershenson; Heidi J Gray; Ardeshir Hakam; Angela Jain; Gottfried E Konecny; John Moroney; Elena Ratner; John Schorge; Premal H Thaker; Theresa L Werner; Emese Zsiros; Kian Behbakht; Lee May Chen; Marie DeRosa; Eric L Eisenhauer; Gary Leiserowitz; Babak Litkouhi; Michael McHale; Sanja Percac Lima; Kerry Rodabaugh; Roberto Vargas; Frankie Jones; Emily Kovach; Lisa Hang; Swathi Ramakrishnan; Ronald D Alvarez; Deborah K Armstrong; ...Mais
PUBLICAÇÃO: 2024, FONTE: Jnccn Journal of the National Comprehensive Cancer Network, VOLUME: 22, NÚMERO: 8

INDEXADO EM:

Scopus

NO MEU:

TÃTULO: Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis.
AUTORES: Vicky Makker; Debra L Richardson; Hye Sook Chon; David Scott Miller ; Morten Mau-Sørensen; David Cibula; Flora Zagouri; Alejandro Pérez Fidalgo; Brian M Slomovitz; Robert L Coleman; Pratheek Kalyanapu; Rong Fan; Girish Gudi; Ignace Vergote;
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology, VOLUME: 42, NÚMERO: 16_suppl

INDEXADO EM:

NO MEU:

ORCID |